One of the mechanisms involves Merlin, the product of the NF2 gene, which is considered a tumour suppressor because its deletion or mutation causes neurofibromatosis type 2, a disease in which a mutated gene is inherited in a dominant form, although there are also cases in which de novo mutations occur [170,171,172]. Here, NF2 is linked to NF2-related schwannomatosis.